Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: Ancillary cardiovascular magnetic resonance study

Heart

Volumn 96, Issue 3, 2010, Pages 190-195

  Haeck, J D ^a   Kuijt, W J ^a,d   Koch, K T ^a   Bilodeau, L ^b   Henriques, J P ^a   Rohling, W J ^a   Baan Jr , J ^a   Vis, M M ^a   Nijveldt, R ^c   Van Geloven, N ^a   Groenink, M ^a   Piek, J J ^a   Tijssen, J G ^a   Krucoff, M W ^d   De Winter, R J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MONTREAL HEART INSTITUTE   (Canada)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; EMBOLISM PREVENTION; FEMALE; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; ST SEGMENT ELEVATION; STROKE; SYSTOLE; THROMBUS ASPIRATION; TREATMENT OUTCOME;

EID: 76149097886     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.180448     Document Type: Article

References (16)

1. Sardella G, Mancone M, Bucciarelli-Ducci C, et al. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. J Am Coll Cardiol 2009;53:309-15.
2. Vlaar PJ, Svilaas T, Van der Horst I, et al. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 2008;371:1915-20.
3. Haeck JD, Koch KT, Bilodeau L, et al. Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration and primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction [abstract]. J Am Coll Cardiol Cardiovasc Interv 2009;2:934-43.
4. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
5. Kim RJ, Albert TS, Wible JH, et al. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation 2008;117:629-37.
6. Koch KT, Haeck JD, van der Schaaf RJ, et al. Proximal embolic protection with aspiration in percutaneous corononary intervention using the proxistrade mark device. Rev Cardiovasc Med 2007;8:160-6.
7. Ripa RS, Jorgensen E, Wang Y, et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006;113:1983-92.
8. Hirsch A, Nijveldt R, Haeck JD, et al. Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. J Am Coll Cardiol 2008;51:2230-8.
9. Kaltoft A, Bottcher M, Nielsen SS, et al. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Circulation 2006;114:40-7.
10. Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005;293: 1063-72.
11. Ito H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nat Clin Pract Cardiovasc Med 2006;3:499- 506.
12. Lerman A, Holmes DR, Herrmann J, et al. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur Heart J 2007;28:788-97.
13. Mauri L, Cox D, Hermiller J, et al. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol 2007;50:1442-9.
14. Coolong A, Baim DS, Kuntz RE, et al. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation 2008;117:790-7.
15. Terkelsen CJ, Kaltoft AK, Norgaard BL, et al. ST changes before and during primary percutaneous coronary intervention predict final infarct size in patients with ST elevation myocardial infarction. J Electrocardiol 2009;42:64-72.
16. Thibault H, Piot C, Staat P, et al. Long-term benefit of postconditioning. Circulation 2008;117:1037-44.